| Title | Clinical characteristics and prognostic factors of pulmonary MALT lymphoma. | | Author(s) | Borie R, Wislez M, Thabut G, Antoine M, Rabbat A, Couderc LJ, Monnet I, Nunes H, Blanc FX, Mal H, Bergeron A, Dusser D, Israël-Biet D, Crestani B, Cadranel J | | Institution | Centre de Compétence Maladies Rares Pulmonaires, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris and Faculté de Médecine Pierre et Marie Curie, Université Paris VI, France; and Service de Pneumologie A, Centre de Compétence Maladies Rares Pulmonaires, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Paris, France. | | Source | Eur Respir J 2009 Jun 18. | | Abstract | MALT lymphoma, a low grade B-cell extranodal lymphoma, is the most frequent subset of primary pulmonary lymphoma. Our objective was to evaluate the initial extent of disease and to analyze the characteristics and long-term outcome of these patients.All chest and pathological departments of teaching hospitals in Paris were contacted to identify patients with a histological diagnosis of primary pulmonary lymphoma of the MALT subtype.Sixty-three cases were identified. The median age was 60 years. Thirty-six percent of cases had no symptoms at diagnosis. Forty-six percent of patients had at least one extra-pulmonary location of lymphoma. The estimated 5- and 10-year overall survival rates were 90% and 72%, respectively. Only two of the nine observed deaths were related to lymphoma. Age and performance-status were the only 2 adverse prognostic factors for survival. Extra-pulmonary location of lymphoma was not a prognostic factor for overall survival nor progression-free survival. Treatment with cyclophosphamide or anthracyclin was associated with shorter progression-free survival, when compared to chlorambucil.The survival data confirm the indolent nature of pulmonary MALT lymphoma. Better progression-free survival was observed with chlorambucil when compared to cyclophosphamide or anthracyclin. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 19541720 |
|
